Cargando…
STAT5b: A master regulator of key biological pathways
The Signal Transducer and Activator of Transcription (STAT)-5 proteins are required in immune regulation and homeostasis and play a crucial role in the development and function of several hematopoietic cells. STAT5b activation is involved in the expression of genes that participate in cell developme...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899847/ https://www.ncbi.nlm.nih.gov/pubmed/36755813 http://dx.doi.org/10.3389/fimmu.2022.1025373 |
_version_ | 1784882721425719296 |
---|---|
author | Smith, Madison R. Satter, Lisa R. Forbes Vargas-Hernández, Alexander |
author_facet | Smith, Madison R. Satter, Lisa R. Forbes Vargas-Hernández, Alexander |
author_sort | Smith, Madison R. |
collection | PubMed |
description | The Signal Transducer and Activator of Transcription (STAT)-5 proteins are required in immune regulation and homeostasis and play a crucial role in the development and function of several hematopoietic cells. STAT5b activation is involved in the expression of genes that participate in cell development, proliferation, and survival. STAT5a and STAT5b are paralogs and only human mutations in STAT5B have been identified leading to immune dysregulation and hematopoietic malignant transformation. The inactivating STAT5B mutations cause impaired post-natal growth, recurrent infections and immune dysregulation, whereas gain of function somatic mutations cause dysregulated allergic inflammation. These mutations are rare, and they are associated with a wide spectrum of clinical manifestations which provide a disease model elucidating the biological mechanism of STAT5 by studying the consequences of perturbations in STAT5 activity. Further, the use of Jak inhibitors as therapy for a variety of autoimmune and malignant disorders has increased substantially heading relevant lessons for the consequences of Jak/STAT immunomodulation from the human model. This review summarizes the biology of the STAT5 proteins, human disease associate with molecular defects in STAT5b, and the connection between aberrant activation of STAT5b and the development of certain cancers. |
format | Online Article Text |
id | pubmed-9899847 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98998472023-02-07 STAT5b: A master regulator of key biological pathways Smith, Madison R. Satter, Lisa R. Forbes Vargas-Hernández, Alexander Front Immunol Immunology The Signal Transducer and Activator of Transcription (STAT)-5 proteins are required in immune regulation and homeostasis and play a crucial role in the development and function of several hematopoietic cells. STAT5b activation is involved in the expression of genes that participate in cell development, proliferation, and survival. STAT5a and STAT5b are paralogs and only human mutations in STAT5B have been identified leading to immune dysregulation and hematopoietic malignant transformation. The inactivating STAT5B mutations cause impaired post-natal growth, recurrent infections and immune dysregulation, whereas gain of function somatic mutations cause dysregulated allergic inflammation. These mutations are rare, and they are associated with a wide spectrum of clinical manifestations which provide a disease model elucidating the biological mechanism of STAT5 by studying the consequences of perturbations in STAT5 activity. Further, the use of Jak inhibitors as therapy for a variety of autoimmune and malignant disorders has increased substantially heading relevant lessons for the consequences of Jak/STAT immunomodulation from the human model. This review summarizes the biology of the STAT5 proteins, human disease associate with molecular defects in STAT5b, and the connection between aberrant activation of STAT5b and the development of certain cancers. Frontiers Media S.A. 2023-01-23 /pmc/articles/PMC9899847/ /pubmed/36755813 http://dx.doi.org/10.3389/fimmu.2022.1025373 Text en Copyright © 2023 Smith, Satter and Vargas-Hernández https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Smith, Madison R. Satter, Lisa R. Forbes Vargas-Hernández, Alexander STAT5b: A master regulator of key biological pathways |
title | STAT5b: A master regulator of key biological pathways |
title_full | STAT5b: A master regulator of key biological pathways |
title_fullStr | STAT5b: A master regulator of key biological pathways |
title_full_unstemmed | STAT5b: A master regulator of key biological pathways |
title_short | STAT5b: A master regulator of key biological pathways |
title_sort | stat5b: a master regulator of key biological pathways |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899847/ https://www.ncbi.nlm.nih.gov/pubmed/36755813 http://dx.doi.org/10.3389/fimmu.2022.1025373 |
work_keys_str_mv | AT smithmadisonr stat5bamasterregulatorofkeybiologicalpathways AT satterlisarforbes stat5bamasterregulatorofkeybiologicalpathways AT vargashernandezalexander stat5bamasterregulatorofkeybiologicalpathways |